Who is sponsoring NCT06127186?

NCT06127186 is sponsored by Marcin Straburzynski.

What drugs are being tested in NCT06127186?

Interventions in NCT06127186: Swab test for viral antigens.

What condition does NCT06127186 study?

NCT06127186 studies Upper Respiratory Tract Infections.

Is NCT06127186 still recruiting?

NCT06127186 is currently completed. Last updated 9 April 2024.

Last reviewed 2024-04-09 · How we verify

NCT06127186

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections

Completed Last updated 9 April 2024

What this trial tests

trial testing Swab test for viral antigens in Upper Respiratory Tract Infections in 223 participants. Completed in 31 March 2024.

Timeline

1 November 2023

Primary endpoint
31 March 2024

31 March 2024

Quick facts

Lead sponsor	Marcin Straburzynski
Status	Completed
Study type	OBSERVATIONAL
Enrollment	223
Start date	1 November 2023
Primary completion	31 March 2024
Estimated completion	31 March 2024
Sites	1 location across Poland

Drugs / interventions tested

Swab test for viral antigens

Conditions studied

Upper Respiratory Tract Infections — all drugs for Upper Respiratory Tract Infections →

Sponsor

Marcin Straburzynski

Who can join

Adults 18 to 65, any sex, with Upper Respiratory Tract Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this longitudinal study is to assess headache and facial pain features in patients with upper respiratory tract infections (URTI). The main question it aims to answer are: 1. What is the phenotype of headache / facial pain in URTIs 2. Does the above mentioned phenotype is associated with: 1. aetiologic factor (virus), 2. type of URTI 3. headache/facial pain experienced by patients in the past. Participants will: * answer standardized questions, * undergo physical examination, * have a swab test performend for antigens of common viruses causing URTI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of sinonasal symptoms in upper respiratory tract infections during the infectious diseases season of November 2023 to March 2024-a cross-sectional study.
Straburzyński M, Romaszko-Wojtowicz A. · · 2024 · PMID 39267977 · DOI 10.3389/fmed.2024.1447467

Verify or expand the search:

Other recruiting trials for Upper Respiratory Tract Infections

Currently open trials in the same condition.

NCT06271655 — Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Dep · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06127186 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marcin Straburzynski
Last refreshed: 9 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06127186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing